BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 15668752)

  • 1. The effect of psoriasis on patients' quality of life and improvements associated with alefacept therapy.
    Menter A
    J Cutan Med Surg; 2004 Dec; 8 Suppl 2():20-5. PubMed ID: 15668752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of alefacept on health-related quality of life in patients with psoriasis: results from a randomized, placebo-controlled phase II trial.
    Ellis CN; Mordin MM; Adler EY;
    Am J Clin Dermatol; 2003; 4(2):131-9. PubMed ID: 12553852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intramuscular alefacept improves health-related quality of life in patients with chronic plaque psoriasis.
    Finlay AY; Salek MS; Haney J;
    Dermatology; 2003; 206(4):307-15. PubMed ID: 12771471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The remittive effects of alefacept.
    Krueger GG
    J Cutan Med Surg; 2004 Dec; 8 Suppl 2():10-3. PubMed ID: 15668750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alefacept in the treatment of psoriasis in patients for whom conventional therapies are inadequate.
    van de Kerkhof P; Griffiths CE; Christophers E; Lebwohl M; Krueger GG
    Dermatology; 2005; 211(3):256-63. PubMed ID: 16205071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alefacept: a novel biologic in the treatment of psoriasis.
    Liu CM; McKenna JK; Krueger GG
    Drugs Today (Barc); 2004 Dec; 40(12):961-74. PubMed ID: 15645008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An overview of infliximab, etanercept, efalizumab, and alefacept as biologic therapy for psoriasis.
    Weinberg JM
    Clin Ther; 2003 Oct; 25(10):2487-505. PubMed ID: 14667953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alefacept: its safety profile, off-label uses, and potential as part of combination therapies for psoriasis.
    Scheinfeld N
    J Dermatolog Treat; 2007; 18(4):197-208. PubMed ID: 17671880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of alefacept in the treatment of psoriasis.
    Wong VK; Lebwohl M
    Skin Therapy Lett; 2003 Sep; 8(6):1-2, 7. PubMed ID: 14610613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alefacept: an expert review concerning the treatment of psoriasis.
    Langley RG; Cherman AM; Gupta AK
    Expert Opin Pharmacother; 2005 Oct; 6(13):2327-33. PubMed ID: 16218892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alefacept for chronic plaque psoriasis: a selective therapy with long-lasting disease remissions and an encouraging safety profile.
    Leone G; Rolston K; Spaulding G
    Dermatol Nurs; 2003 Jun; 15(3):216-20, 224-5; quiz 226. PubMed ID: 12875010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and use of alefacept to treat psoriasis.
    Krueger GG; Callis KP
    J Am Acad Dermatol; 2003 Aug; 49(2 Suppl):S87-97. PubMed ID: 12894131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective targeting of T cell subsets: focus on alefacept - a remittive therapy for psoriasis.
    Krueger GG
    Expert Opin Biol Ther; 2002 Apr; 2(4):431-41. PubMed ID: 11955280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alefacept for the treatment of psoriasis: a review of the current literature and practical suggestions for everyday clinical use.
    Korman NJ; Moul DK
    Semin Cutan Med Surg; 2005 Mar; 24(1):10-8. PubMed ID: 15900794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alefacept: a novel and selective biologic agent for the treatment of chronic plaque psoriasis.
    Ortonne JP; Prinz JC
    Eur J Dermatol; 2004; 14(1):41-5. PubMed ID: 14965795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alefacept for the treatment of psoriasis and other dermatologic diseases.
    Strober BE; Menon K
    Dermatol Ther; 2007; 20(4):270-6. PubMed ID: 17970892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient satisfaction with psoriasis therapies: an update and introduction to biologic therapy.
    Finlay AY; Ortonne JP
    J Cutan Med Surg; 2004; 8(5):310-20. PubMed ID: 15868312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical update on alefacept: consideration for use in patients with psoriasis.
    Gade JN
    J Manag Care Pharm; 2004 Jun; 10(3 Suppl B):S33-7. PubMed ID: 15253688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alefacept in the treatment of psoriasis.
    Sugiyama H; McCormick TS; Cooper KD; Korman NJ
    Clin Dermatol; 2008; 26(5):503-8. PubMed ID: 18755368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative effects of biological therapies on the severity of skin symptoms and health-related quality of life in patients with plaque-type psoriasis: a meta-analysis.
    Reich K; Sinclair R; Roberts G; Griffiths CE; Tabberer M; Barker J
    Curr Med Res Opin; 2008 May; 24(5):1237-54. PubMed ID: 18355421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.